VRTX

VRTX Other Current Assets

$791.90MQuarterly · USD

Period ending:

VRTX FY Other Current AssetsUSD
VRTX FY Other Current Assets1990-12-31: $200.00K1991-12-31: $24.10M1992-12-31: $32.40M1993-12-31: $24.50M1994-12-31: $35.30M1995-12-31: $59.50M1996-12-31: $97.30M1997-12-31: $210.10M1998-12-31: $224.50M1999-12-31: $1.44M2000-12-31: $9.46M2001-12-31: $12.63M2002-12-31: $8.39M2003-12-31: $3.32M2004-12-31: $2.50M2005-12-31: $3.30M2006-12-31: $3.86M2007-12-31: $4.66M2008-12-31: $11.99M2009-12-31: $12.51M2010-12-31: $13.10M2011-12-31: $66.77M2012-12-31: $94.66M2013-12-31: $15.88M2014-12-31: $38.50M2015-12-31: $118.96M2016-12-31: $83.90M2017-12-31: $62.48M2018-12-31: $140.82M2019-12-31: $213.52M2020-12-31: $308.32M2021-12-31: $545.80M2022-12-31: $553.50M2023-12-31: $623.70M2024-12-31: $665.70M2025-12-31: $850.30M$850.30M$0.00
1990-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

VRTX other current assets history

Current assets not classified elsewhere. The available annual fiscal periods series contains 36 observations from Dec 31, 1990 to Dec 31, 2025.

Vertex Pharmaceuticals Other Current Assets — Annual fiscal periods (USD)
Period endingOther Current Assets (USD)
850,300,000
665,700,000
623,700,000
553,500,000
545,800,000
308,323,000
213,515,000
140,819,000
62,475,000
83,896,000
118,964,000
38,500,000
15,877,000
94,656,000
66,767,000
13,099,000
12,512,000
11,991,000
4,660,000
3,857,000
3,303,000
2,501,000
3,318,000
8,388,000
12,625,000
9,464,000
1,439,000
224,500,000
210,100,000
97,300,000
59,500,000
35,300,000
24,500,000
32,400,000
24,100,000
200,000

Compare other current assets

All VRTX financial metrics · VRTX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.